Tokyo, May 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061358) titled 'Accuracy verification study of a non-invasive eye positioning system in carbon ion radiotherapy for choroidal melanoma' on May 1.
Study Type:
Observational
Primary Sponsor:
Institute - National Institutes for Quantum Science and Technology
Condition:
Condition - Choroidal melanoma
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To verify the accuracy of eye positioning using the iris, rather than metal markers.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1. Patients with choroidal melanoma who have undergone metal marker suturing
2. can follow medical instructions
3. have provided written consent.
Key exclusion criteria - Patients who cannot remain still.
Target Size - 10
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 03 Month 23 Day
Date of IRB - 2026 Year 04 Month 09 Day
Anticipated trial start date - 2026 Year 05 Month 01 Day
Last follow-up date - 2027 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070114
Disclaimer: Curated by HT Syndication.
